Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Johan Aasbo

Clinical Cardiac Electrophysiology Lexington, KY Medical Doctor

NPI 1396820213 CMS profile 244518

1720 Nicholasville Rd Ste 601, Lexington, KY 40503

Open in the dashboard

General payments

$450,929

671 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$364,253 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Johan Aasbo of Lexington, KY is reported in the CMS Open Payments database as having received $450,929 across 671 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $364,253 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $276,562 182
2024 General $72,034 101
2023 General $40,836 103
2022 General $30,281 94
2021 General $5,610 53
2020 General $5,698 64
2019 General $19,909 74

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Johan Aasbo
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Johan Aasbo were reported at $276,562. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Johan Aasbo Clinical Cardiac Electrophysiology median Middle half National median
2019 $19,909 $2,361 $585–$8,260 $163
2020 $5,698 $993 $247–$4,351 $114
2021 $5,610 $1,185 $326–$4,739 $132
2022 $30,281 $2,073 $554–$6,789 $149
2023 $40,836 $2,568 $759–$8,159 $160
2024 $72,034 $2,557 $703–$7,403 $164
2025 $276,562 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $407,900 429 payments
  2. Biotronik Inc. $17,516 52 payments
  3. Respicardia, Inc. $9,485 13 payments
  4. Abbott Laboratories $3,617 41 payments
  5. Impulse Dynamics (USA) Inc. $3,584 7 payments
  6. Acutus Medical, Inc. $2,312 10 payments
  7. Biosense Webster, Inc. $1,669 11 payments
  8. Medtronic Vascular, Inc. $1,530 12 payments
  9. Atricure, Inc. $766 11 payments
  10. Vektor Medical Inc. $500 1 payment
  11. Other $2,050 84 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $376,213 141 payments
  2. Travel and Lodging $25,505 77 payments
  3. Food and Beverage $20,380 437 payments
  4. Consulting Fee $13,856 7 payments
  5. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $7,050 4 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $5,500 3 payments
  7. Honoraria $2,400 1 payment
  8. Entertainment $26 1 payment
Products named General payments · program years 2019–2025
  1. General - EP $230,210 90 payments
  2. EMBLEM MRI S-ICD $63,599 67 payments
  3. Rhythmia Mapping System Rhythmia_EP $16,930 22 payments
  4. Rhythmia Mapping System Rhythmia Simulator_CRM $13,500 15 payments
  5. General - Therapies $11,564 20 payments
  6. S-ICD System Magnet $9,765 15 payments
  7. remede System $9,485 13 payments
  8. CLINICAL TRIAL PRODUCT $4,563 5 payments
  9. WATCHMAN FLX $4,425 7 payments
  10. OPTIMIZER $3,550 6 payments
  11. Other $33,870 365 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 30 drugs

Part D claims

1,601

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$660,654

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

53.9%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 430 $437,802
Xarelto Rivaroxaban Brand 106 $121,752
Entresto Sacubitril/Valsartan Brand 39 $32,588
Multaq Dronedarone Hcl Brand 25 $29,344
Flecainide Acetate Generic 133 $10,385
Jardiance Empagliflozin Brand 14 $8,450
Dabigatran Etexilate Dabigatran Etexilate Mesylate Brand 15 $4,195
Dofetilide Generic 35 $3,617
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 50 $2,282
Amiodarone Hcl Generic 34 $1,983

The 10 drugs with the highest cost, of 30 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 72 billing codes

Paid by Medicare

$242,615

Medicare's payments for the services billed

Medicare patients

1,039

Average age 76

Services billed

4,047

489 women, 550 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 67%
Ischemic heart disease 61%
Arthritis 57%
Heart failure 51%
Diabetes 43%
Chronic kidney disease 38%
COPD 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 6 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Repatha
  • Amgen Inc. $19
$19 — —
ELIQUIS
  • PFIZER INC. $11
$11 430 —
NURTEC ODT
  • PFIZER INC. $11
$11 — —
PAXLOVID
  • PFIZER INC. $11
$11 — —
RYBELSUS
  • Novo Nordisk Inc $7
$7 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 6 in the dashboard with a free account

Records

671 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record